Biotechnology

Life Sciences

Nutraceutical

6 Signs Of Collagen Deficiency

When people think of collagen, they typically think of the skin. This is a fair ...

5 Things That Destroy Your Collagen

Collagen is the most abundant protein in the body. It’s responsible for giving s...

Should Older Adults Take Collagen?

Collagen is the most abundant protein in the human body. It plays a role in the ...

Latest Posts

View All Posts
Pharmaceutical

FDA approves Amneal and Shilpa’s oncology product BORUZU

The US FDA has approved Amneal Pharmaceuticals and Shilpa Medicare’s oncology pr...

Pharmaceutical

Evotec partners X-Chem for tech-enabled drug discovery

German life science company Evotec has announced a collaboration with X-Chem to ...

Pharmaceutical

NImmune and BioTherapeutics partner on precision medici...

NImmune Biopharma and BioTherapeutics have partnered to develop new precision me...

Pharmaceutical

FDA grants ODD to Abdera’s neuroendocrine carcinoma tre...

The US FDA has granted orphan drug designation (ODD) to Abdera Therapeutics’ ABD...

Pharmaceutical

GSK’s asthma blockbuster Nucala secures win in COPD Pha...

GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.

Pharmaceutical

Men taking valproate and their partners warned to use c...

A study suggests that children may face a higher risk of harm if their father is...

Pharmaceutical

Investment opportunities in atopic dermatitis may drive...

The atopic dermatitis market is facing increased growth, with a projected market...

Pharmaceutical

After failed FSGS bid, Travere wins full FDA approval f...

The company had focused its resources on Filspari’s launch in IgAN after the US ...

Pharmaceutical

Biogen’s higher Spinraza dose shows better efficacy in ...

Biogen plans to apply for regulatory approval of this investigational dose regim...

Life Sciences

Onward awarded $1.1M grant from the Christopher & Dana ...

Onward Medical revealed that it has received a major grant from the Christopher ...

Life Sciences

Illumina Gets Favorable Decision Regarding Grail Acquis...

In a decision expected to limit Brussels’ merger authority, American gene sequen...

Life Sciences

Sanofi’s Tolebrutinib faces defeat in 2 out of 3 phase ...

Sanofi has announced that tolebrutinib, a BTK inhibitor, failed in two out of th...

12